Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways.

Endocrinology - 1 Oct 1997

Thibonnier M, Preston J A, Dulin N, Wilkins P L, Berti-Mattera L N, Mattera R

Abstract excerpt

The vasopressin (AVP) V3 pituitary receptor (V3R) is a G protein-coupled corticotropic phenotypic marker that is overexpressed in ACTH-hypersecreting tumors. Studies of the agonist/antagonist binding profile and signal transduction pathways linked to the human V3R have been limited because of the scarcity of this protein. To define the signals activated by V3Rs and the eventual changes triggered by developmental...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to Cell Division
Share to Cricetinae

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Dose-Response Relationship, Drug

Share to Phenotype

Share to Phosphorylation

Share to Protein Binding

Source

Identifiers

PMID: 9322919
DOI: 10.1210/endo.138.10.5432

Genes

AVP

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The human V3 pituitary vasopressin receptor: ligand binding profile and density-dependent signaling pathways.PMID 9322919Read ↗

V3 vasopressin receptor and corticotropic phenotype in pituitary and nonpituitary tumors.Semantic proximity Read ↗

Vasopressin receptors modulate the pharmacological phenotypes of Cushing's syndrome.Semantic proximity Read ↗

The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome.Semantic proximity Read ↗

Overexpression of vasopressin (V3) and corticotrophin‐releasing hormone receptor genes in corticotroph tumoursSemantic proximity Read ↗

Two vasopressin type 2 receptor gene mutations R143P and delta V278 in patients with nephrogenic diabetes insipidus impair ligand binding of the receptor.Semantic proximity Read ↗

Molecular cloning, sequencing, and functional expression of a cDNA encoding the human V1a vasopressin receptor.Semantic proximity Read ↗

Molecular cloning and expression of a pituitary-specific receptor for growth hormone-releasing hormone.Semantic proximity Read ↗

Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor.Semantic proximity Read ↗

Differential signaling and immediate-early gene activation by four splice variants of the human pituitary adenylate cyclase-activating polypeptide receptor (hPACAP-R).Semantic proximity Read ↗

Variable expression of the V1 vasopressin receptor modulates the phenotypic response of steroid-secreting adrenocortical tumors.Semantic proximity Read ↗

Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U‐937 cellsSemantic proximity Read ↗

Molecular Identification and Analysis of a Novel Human Corticotropin-Releasing Factor (CRF) Receptor: The CRF2γ ReceptorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.